Ealing geko VLU study

• Research type

  Research Study

• Full title

  A single centre open label pilot study measuring lower limb arterial and venous blood flow in patients with venous leg ulcers using the geko™ T-2 or gekoTM plus [R-2] neuromuscular electro stimulation device

• IRAS ID

  185818

• Contact name

  Matthew Womack

• Contact email

  matthew.womack@firstkindmedical.com

• Sponsor organisation

  Firstkind Ltd

• Clinicaltrials.gov Identifier

  NCT02482038

• Duration of Study in the UK

  0 years, 7 months, 21 days

• Research summary

  The geko device has been shown to increase lower limb blood flow in healthy volunteers. It is postulated that if similar increases in blood flow are observed in patients with a compromised vasculature (i.e with venous leg ulcers [VLU]) then improvements in their underlying condition may be possible.

  This pilot study sets out to show if patients with venous leg ulcers also show increased blood flow when using the geko™ (T-2 or R-2) devices. If this is observed a later study will be designed with clinical endpoints.

• REC name

  London - Stanmore Research Ethics Committee

• REC reference

  16/LO/1091

• Date of REC Opinion

  10 Jun 2016

• REC opinion

  Favourable Opinion